Tenet Healthcare Corp (THC)

被低估

HealthcareMedical Care FacilitiesUnited States

基本面

价格

$259.78

市值

$20.77B

Yahoo Finance TradingView 新闻官网

第一部分 · 这家公司值多少

概览

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

资产负债表与流动性

营收

$21.81B

最近12个月（截至2026/6/30）

净利润

$3.17B

最近12个月（截至2026/6/30）

自由现金流

$2.53B

股东权益合计

$4.22B

负债合计

$20.70B

流动比率

1.41

利息覆盖率

5.54

债务/EBITDA

3.03

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

一般情形被低估

公允价值

$610.78

当前价格

$259.78

安全边际

+57.5%

公允价值区间

$397.01 - $824.55

所用估值方法之间的离散区间，并非经过统计校准的置信区间。

估算方法

分析师目标价:$284.64

现金流折现法（DCF）:$1054.22

市盈率法（P/E）:$314.40

格雷厄姆成长公式:$1331.27

盈利能力价值（EPV）:$380.62

合理市净率（P/B）:$268.25

股息折现模型（戈登模型）:数据不足，无法计算

P/FFO（运营资金）:$641.84

周期中段收益:$620.65

市销率法（P/S）:$1038.88

分析师共识:强力买入 (23B / 4H / 0S)

最近财报超预期:+43.62%

估值指标

市盈率（P/E）

9.79

ROE

56.1%

市净率（P/B）

4.39

P/FCF

6.76

毛利率

ROIC

14.3%

盈利能力雷达图

价值创造（经济护城河）

ROIC

14.3%

WACC

8.8%

ROIC − WACC

+5.5 pp

ROIC 超过资本成本：公司正在为股东创造价值。

基本面分析标准

通过（18）

EPS shows upward trend
EPS CAGR 40.13%
Price CAGR 33.35%
ROIC 14.3%
P/FCF 6.76
Operating Margin 20.8%
Positive Free Cash Flow
Current Ratio
Interest Coverage
Debt/EBITDA
Return on Tangible Assets
ROE 50.6%
Analyst Consensus 85% Buy
Earnings Surprise avg 20.9%
PEG Ratio 0.28
Earnings Quality (OCF/NI) 1.26
Net Margin Trend 14.6% vs 11.6%
Piotroski F-Score 5/9

未通过（8）

P/B Ratio 4.39
Debt/Equity ratio
CapEx intensity
Low reliance on intangibles
Price below Graham Number
DCF valuation (Overvalued)
Revenue Growth 5Y 3.9%
Share Dilution 23.0%

不可用（2）

Gross Margin NaN%
Dividend Payout NaN%

Piotroski F-评分

5/9

信号混杂：部分领域需关注

score

criteria

盈利质量

1.26

高质量：盈利有现金流支撑

股权稀释

23.0%

正在发行新股，稀释所有权

机构持股

公司治理

管理团队

姓名	职位	年龄
Dr. Saumya Sutaria M.D.	Chairman & CEO	52
Mr. Sun K. Park	Executive VP & CFO	49
Ms. Lisa Y. Foo	Executive VP & Chief Operating Officer	34
Ms. Paola M. Arbour	Executive VP & Chief Information Officer	61
Mr. Thomas W. Arnst	EVP, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary	62
Mr. John Michael Grooms	Senior VP, Controller & Principal Accounting Officer	47
Mr. William McDowell III	Vice President of Investor Relations	-
Ms. Jana Durfee	Senior VP & Chief Compliance Officer	-
Mr. Michael T. Maloney	Executive Vice President of Corporate Development	-
Mr. Clint Hailey	Chief Managed Care Officer & Senior VP	60

审计风险

董事会风险

薪酬风险

股东权利风险

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有：它帮助你在基本面说服你之后，选择何时买入。包含：技术分析、潜力、历史回撤、Gamma 敞口。

文件

年度报告（10-K）
对公司业务、财务业绩和风险的年度概述。
提交日期：2026-02-17
查看文件
季度报告（10-Q）
最近三个月财务表现的最新情况。
提交日期：2026-07-29
查看文件
临时报告（8-K）
关于重大事件（如管理层变动或重要公告）的通知。
提交日期：2026-09-22
查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for THC, sourced from Markets Gazette.

2/20/2026POSITIVE
The Analyst Verdict: Tenet Healthcare In The Eyes Of 12 Experts
Recent analyst ratings for Tenet Healthcare (THC) show a predominantly positive sentiment, with multiple experts maintaining or reinstating "Buy" ratings. This suggests a favorable outlook for the stock, based on fundamental analysis or future growth prospects.

via Markets Gazette